Clinical Trial Update: Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer

View source ↗

Summary

This clinical trial update reports on the prognostic significance of PD-L1 expression in advanced endometrial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Institut de Cancérologie de Lorraine | Conditions: Endometrial Cancer | Status: COMPLETED